Skip to main content

UCSF

ObGyn&RS

Reproductive Endocrinology & Infertility

Yanett Anaya
Yanett Anaya, MD

Reproductive Endocrinologist

If you are a patient, please do not contact this physician by email without her prior expressed consent due to confidentiality concerns.

Contact Information

Mailing Address:  499 Illinois St. 6th Floor
San Francisco, CA 94158
Practice Phone: 415-353-7475

Research/Clinical Interests

Assisted reproduction, fertility preservation, polycystic ovarian syndrome (PCOS), premature ovarian insufficiency.

Education/Training

Year Institution & Location Degree Field of Study
2009 The University of Texas Health Science Center, San Antonio M.D. Medicine
2013 Baylor College of Medicine, Houston  Residency Obstetrics and Gynecology 
2016 University of California, San Francisco, San Francisco Fellowship Reproductive Endocrinology and Infertility 

Achievements & Recognition

Year Major Honors
2011 Research grant awarded by the Department of Obstetrics and Gynecology, BCM
2012

American Congress of Obstetricians and Gynecologists (ACOG)

John Burch Endowment Fund Travel Award

2012

Arthur M. Farris Resident Research Day, Oral Presentation -

1st place, Distinct Pathways Involved in Endometriosis-Associated Ovarian Cancer

2012

Best Resident Award in the Division of Women’s Law and Health Policy,

Department of Obstetrics and Gynecology, BCM

2012

PGY3 Resident of the Year Award, Department of Obstetrics and

Gynecology, BCM

Selected Publications

Poirier C, Qin Y, Adams CP, Anaya Y, Singer JB, Hill AE, Lander ES, Nadeau JH, Bishop CE. A complex interaction of imprinted and maternal-effect genes modifies sex determination in Odd Sex (Ods) mice. Genetics. 2004; 168(3): 1557-1562.

Herndon CN, Anaya Y, Noel M, Cakmak H, Cedars MI. Outcomes from a university-based low-cost in vitro fertilization program providing access to care for a low resource socioculturally diverse urban community. Fert Steril. 2017;108(4):642-649.

Anaya Y, Mata DA, Letourneau J, Cakmak H, Cedars MI, Rosen MP. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization protocols. J Assist Reprod Genet. 2018;35(2):297-307.